Unum Taps Former Takeda Oncology Exec, Vasconcelles, as CMO
Michael Vasconcelles has been named the chief medical officer of Cambridge, MA-based cellular immunotherapy startup Unum Therapeutics. Vasconcelles was previously the head of oncology at Takeda Pharmaceuticals. Unum, meanwhile, raised a $65 million Series B round in June to lay the foundation for a future IPO.
More from EXOME
Trending on Xconomy
Underwriters and Partners
Xpertise: Watch + Learn
Sponsored · Whitepaper
What to Include in Your Life Sciences Company Fundraising Pitch Deck
What the most successful life sciences fundraising pitch decks all have in common
Brex
From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Key indicators & expert insight from industry leaders
Xconomy
Sponsored · Whitepaper
Accelerating Life Sciences Product Development & Commercialization
Best practices to drive digital adoption in life sciences
DocuSign